Home > Balance Sheet > BAL PHARMA

BAL PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Total Non-Current Liabilities ₹38 Cr₹36 Cr₹34 Cr₹34 Cr₹38 Cr

What is the latest Total Non-Current Liabilities ratio of BAL PHARMA ?

The latest Total Non-Current Liabilities ratio of BAL PHARMA is ₹38 Cr based on Mar2023 Consolidated results.
Year Total Non-Current Liabilities
Mar2023₹38 Cr
Mar2022₹36 Cr
Mar2021₹34 Cr
Mar2020₹34 Cr
Mar2019₹38 Cr

How is Total Non-Current Liabilities of BAL PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2023 ₹38 Cr
4.32
Mar2022 ₹36 Cr
6.44
Mar2021 ₹34 Cr
1.87
Mar2020 ₹34 Cr
-11.32
Mar2019 ₹38 Cr -

Compare Total Non-Current Liabilities of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹157.7 Cr -3% -1.1% 17.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹356,673.0 Cr -2.9% 0% 59.6% Stock Analytics
CIPLA ₹119,930.0 Cr 5.8% 6.2% 60.9% Stock Analytics
DIVIS LABORATORIES ₹109,446.0 Cr 5% 8% 25.9% Stock Analytics
ZYDUS LIFESCIENCES ₹108,261.0 Cr -2.6% 15.3% 114.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,830.6 Cr 0.9% -1.5% 32.2% Stock Analytics


BAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-3%

-1.1%

17.9%

SENSEX

2%

2.3%

22.2%


You may also like the below Video Courses